Showing results (51-60 of 58) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
AIDS (London, England)|November 24, 1999
Lymph node architecture preceding and following 6 months of potent antiviral therapy: follicular hyperplasia persists in parallel with p24 antigen restoration after involution and CD4 cell depletion in an AIDS patientJ M Orenstein, M Feinberg, C Yoder, et al.The Journal of Infectious Diseases|March 9, 1999
A randomized trial of high- versus low-dose subcutaneous interleukin-2 outpatient therapy for early human immunodeficiency virus type 1 infectionR T Davey, D G Chaitt, J M Albert, et al.European Journal of Immunology|July 24, 2001
Interleukin-2 induced immune effects in human immunodeficiency virus-infected patients receiving intermittent interleukin-2 immunotherapyJ A Kovacs, S Vogel, J A Metcalf, et al.Nature Medicine|July 14, 1998
Peripheral expansion of pre-existing mature T cells is an important means of CD4+ T-cell regeneration HIV-infected adultsR E Walker, C S Carter, L Muul, et al.Antimicrobial Agents and Chemotherapy|July 1, 1996
Randomized, controlled phase I/II, trial of combination therapy with delavirdine (U-90152S) and conventional nucleosides in human immunodeficiency virus type 1-infected patientsR T Davey, D G Chaitt, G F Reed, et al.JAMA|November 30, 1999
Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitisS M Whitcup, E Fortin, A S Lindblad, et al.Proceedings of the National Academy of Sciences of the United States of America|December 28, 1999
HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppressionR T Davey, N Bhat, C Yoder, et al.Blood|July 11, 2000
Long-term in vivo survival of receptor-modified syngeneic T cells in patients with human immunodeficiency virus infectionR E Walker, C M Bechtel, V Natarajan, et al.Pageof 6